News
December 2022
-
Cancer CareDecember 05, 2022
Canine cancer patient gets new lease on life while helping people fighting same disease
A partnership between UC Davis Comprehensive Cancer Center and UC Davis School of Veterinary Medicine hopes to help cure cancer in both people and pets.
Read More -
MIND InstituteDecember 02, 2022Finding better ways to measure cognitive change in people with intellectual disability
A new UC Davis MIND Institute study finds the NIH Toolbox Cognition Battery is a promising option for measuring cognitive change in people with intellectual disability.
Read More
November 2022
-
ResearchNovember 21, 2022Physicians urged to consider fungal infections as possible cause for lung inflammation
Infectious diseases expert George Thompson warns of the rising threat and apparent spread of disease-causing fungi outside their traditional hot spots. Fungal lung infections are commonly misdiagnosed, leading to delays in treatment and increase in antimicrobial resistance in the community.
Read More -
Emergency CareNovember 16, 2022NIH awards emergency medicine physicians two grants
The Department of Emergency Medicine has been awarded two National Institutes of Health grants totaling over $5 million to improve patient care. They include an effort to better evaluate pediatric trauma patients and another to identify effective treatments early in emergency care.
Read More -
November 15, 2022
Sacramento woman celebrates 100th clinical trial dose, cancer-free
A Sacramento woman celebrates the 100th dose of a clinical trial therapy that has left her cancer free. The Phase II clinical trial at UC Davis Comprehensive Cancer Center combines two immunotherapy drugs that lower toxicity and lengthen remission.
Read More -
ResearchNovember 07, 2022UC Davis gets $15 million to develop and assess AI for breast cancer detection, risk model
A team led by Diana Miglioretti, chief of biostatistics at UC Davis, won a $15 million NCI grant to develop models and use artificial intelligence to make breast cancer screening and surveillance more accurate and equitable.
Read More
October 2022
-
Cancer CareOctober 21, 2022Study finds earlier mammograms for women with family history of breast cancer may not be needed
A UC Davis Comprehensive Cancer Center researcher helped lead a new study that may prompt medical experts to rethink when to start mammograms for women who have a mother, sister or daughter diagnosed with breast cancer.
Read More -
Children's HealthOctober 19, 2022Study finds caregiver-child relationships improved after seven-session intervention
A new study by researchers at UC Davis Children’s Hospital uses the first randomized controlled trial to evaluate PC-CARE’s effectiveness for children with challenging behaviors and their parents or caregivers. The study’s findings were recently published in the Journal of Child Psychiatry Human Development.
Read More -
ResearchOctober 06, 2022What you need to know about shellfish allergy diagnosis, treatment
Shellfish is the leading cause of food allergy in the U.S. In this Q& A, Patrick Leung, professor of rheumatology, allergy and clinical immunology at UC Davis Health, answers questions on the latest advances in diagnosing and treating shellfish allergies.
Read More -
Children's HealthOctober 06, 2022
World’s first stem cell treatment for spina bifida delivered during fetal surgery
Three babies have been born after receiving the world’s first spina bifida treatment combining surgery with stem cells. This was made possible by a landmark clinical trial at UC Davis Health known formally as the “CuRe Trial: Cellular Therapy for In Utero Repair of Myelomeningocele.”
Read More -
Neurological HealthOctober 05, 2022When it comes to faces, context matters
Context shapes our perception of facial expressions during everyday social interactions. A recent UC Davis Health study identified where in the brain these neural computations take place and how, based on context, the different parts of the brain interact to determine facial perception.
Read More -
Neurological HealthOctober 05, 2022Symposium at UC Davis showcases range of medical applications for light-based technologies
The National Center for Interventional Biophotonic Technologies hosted its inaugural symposium September 29 and 30, bringing together leading researchers from 13 institutions. The light-based technologies being developed have the potential to transform how diseases are diagnosed, managed, and treated.
Read More -
ResearchOctober 04, 2022UC Davis neuroscientist Sergey Stavisky wins 2022 NIH Director’s New Innovator Award
UC Davis Health neuroscientist Sergey Stavisky was selected by the National Institutes of Health to receive the 2022 NIH Director’s New Innovator Award. The $2.3 million award will fund his research on medical devices implanted in the brain to restore speech.
Read More
September 2022
-
ResearchSeptember 28, 2022CDC grant to study risks of combined use of opioids and ‘benzos’
UC Davis Health researchers received a $1.05 million grant from the Centers for Disease Control and Prevention to identify risk and protective factors linked to the combined use of opioids and benzodiazepines, a group of drugs used to treat anxiety and insomnia.
Read More -
ResearchSeptember 23, 2022Uncovering the skin’s secrets: Studies show how skin forms differently across the body
Two recent UC Davis studies reveal how skin forms differently across different areas of the body from the face and underarms to the palms of our hands and feet. By profiling the changes in skin, researchers found that the differences have a direct impact for how various skin diseases form across the body.
Read More -
ResearchSeptember 22, 2022Breaking the loop leading to muscular fibrosis
When an injury doesn’t heal correctly, fibrosis and scar tissue form in the muscles. A UC Davis team may have unlocked a way to prevent muscular fibrosis by preventing stem cells from getting stuck in an endless loop of collagen production.
Read More -
Clinical ScienceSeptember 21, 2022UC Davis researchers explore new angle on pancreatic islet function
UC Davis researchers have shown for the first time that the signaling protein 14-3-3-zeta can shift pancreatic alpha cells from producing glucagon, which increases blood glucose, to make the antidiabetic hormone GLP-1. These findings could lead to new therapies for people with type 2 diabetes.
Read More -
ResearchSeptember 21, 2022
Could monoclonal antibodies replace opioids for chronic pain?
During the pandemic, physicians used infusions of monoclonal antibodies to help patients fight off COVID-19 infections. Now, in response to the U.S. opioid crisis, researchers at UC Davis are trying to create monoclonal antibodies that can help fight chronic pain.
Read More -
Eye Health and Vision ScienceSeptember 13, 2022$4 million donation from Daryl Geweke supports glaucoma research and treatment
The Eye Center at UC Davis Health has two new endowed chairs focused on glaucoma research and treatment, thanks to a $4 million donation from business entrepreneur Daryl Geweke. James D. Brandt and Nicholas R. Marsh-Armstrong are the inaugural holders of the new endowed chairs.
Read More -
Medical CenterSeptember 08, 2022UC Davis Health recruiting for study on using both implant, birth control pills
Are two birth control methods better than one? UC Davis Health is one of three centers in the United States, investigating if patients are willing to use both a birth control pill and a hormonal birth control implant at the same time.
Read More -
Violence PreventionSeptember 06, 2022New study finds racial and ethnic differences in perception and use of ‘red flag’ laws
Although extreme risk protection orders (ERPOs) show promise in preventing firearm violence, new research from the Violence Prevention Research Program finds racial and ethnic differences in how ERPOs are perceived and used in California.
Read More -
ResearchSeptember 01, 2022Pilot grants fund research into opioid use, ADHD, firearm suicide prevention
The Behavioral Health Center of Excellence at UC Davis has awarded six pilot grants to advance mental health research. The program aims to improve mental health in California by investing in research on critical issues facing society.
Read More
August 2022
-
CoronavirusAugust 31, 2022High folic acid associated with higher rates of COVID-19 infections and mortality
A new study that looked at health data from the UK found people with a folic acid prescription were 1.5 times as likely to get COVID-19 and were more than 2.6 times as likely to die from COVID-19 compared to the control group.
Read More -
Internal MedicineAugust 31, 2022New study aims to identify ethnicity-specific markers for non-alcoholic fatty liver disease
Researchers have performed a first-of-its-kind study to better understand why non-alcoholic fatty liver disease affects certain races or ethnicities disproportionately. Initial findings suggest ethnicity-specific lipidomic signatures may characterize and explain the progression of the disease for certain races.
Read More -
Clinical ScienceAugust 30, 2022Novel study investigates cell therapy to treat swallowing disorders
This therapy could be a potential game-changer for our patients who suffer from difficulty swallowing, many of whom are cancer survivors living with the consequences of radiation toxicity.”
Read More -
ResearchAugust 26, 2022UC Davis Health study reports on the safety, efficacy of tecovirimat in treating monkeypox
UC Davis Health has published one of the earliest studies assessing the use of tecovirimat to treat monkeypox symptoms and skin lesions. The antiviral drug approved for smallpox treatment appeared to be safe and effective in 25 patients with monkeypox.
Read More -
Cancer CareAugust 24, 2022California Department of Public Health awards UC Davis $15.7M to manage Cancer Registry
The California Department of Public Health has awarded UC Davis Health a $15.7 million grant to co-manage California Cancer Registry. The registry is a valuable resource for cancer researchers, health policymakers and the public. It has detailed information on nearly 6 million cancer cases in California.
Read More -
School of MedicineAugust 22, 2022Surgery resident awarded prestigious T32 federal research grant
Cardiothoracic surgery resident Nataliya Bahatyrevich has become the latest UC Davis trainee to receive a prestigious T32 federal research grant. The award will allow her to spend a year in the laboratory and pursue a Master of Science in biomedical engineering at UC Davis
Read More -
Neurological HealthAugust 18, 2022Clinical trial aims to develop new methods to restore speech with brain-computer interface
UC Davis Health is recruiting people for a clinical trial, BrainGate2, with the goal of building a “neurological prosthesis” for restoring speech to people who have lost — or are losing — the ability to speak due to injuries like stroke or diseases like ALS.
Read More -
UnderservedAugust 17, 2022UC Davis launches a science academy for youth in underserved communities to study health
The UC Davis CTSC and community partner Urban Advocates and Achievers are offering the Youth Community Scientist Academy in Health Research, a 10-week educational program for high school-age students in the Oak Park, Del Paso Heights, and other Promise Zone neighborhoods of Sacramento. Registration is now open.
Read More
Clinical Trials at UC Davis
-
Together we can make a difference
The importance of clinical trialsSearch for clinical trials at UC DavisThis short (1 minute, 45 seconds) video highlights reasons to participate in clinical trials.
